Abu Dhabi-based technology group G42 said on 22 October that it and five portfolio companies had signed memorandums of understanding with Greek public- and private-sector partners to explore cooperation in AI infrastructure, public services, life sciences and smart cities. G42 describes the initiatives as an extension into Europe of its “Intelligence Grid” concept, spanning data centres, advanced computing, cloud infrastructure and sector-specific applications. The announcement sets out frameworks and areas for exploration; it does not announce a firm investment, construction decision or service launch.

For infrastructure, G42 companies Khazna Data Centers and Core42 will explore developing an “AI factory” in Greece with Copelouzos Group. G42 says Khazna could lead physical data-centre infrastructure, while Core42 could provide cloud and AI compute capabilities. The release lists banking, telecommunications, shipping and government among potential user sectors. It does not disclose a site, capacity, power requirement, budget, financing structure or construction timetable. The proposed facility should not be described as an investment-approved or under-construction data centre.

Other MoUs focus on potential public and municipal applications. G42 subsidiary Presight will explore AI-powered analytics with Greece’s Ministry of Digital Governance for urban mobility and municipal operations, initially looking at waste management and water-network monitoring. Inception42 will work with the ministry on possible government and education applications, including AI tools for cabinet meetings, monitoring government priorities, AI-agent training and learning platforms. The announcement describes areas for study and demonstration, not nationwide deployment.

In life sciences, M42 signed an MoU with Athens LifeTech Park covering research, genomics sequencing infrastructure, clinical development and connections between institutional biobanks. G42 identifies oncology, rare genetic diseases and neuroscience as potential priority areas. It also describes a possible two-way programme through which UAE life-sciences start-ups could use the Greek park’s incubator for European market entry, while Greek and European ventures could access the UAE through M42’s network. These are proposed cooperation areas rather than announced clinical studies or company investments.

G42 says the parties will next define the scope, structure and timelines of each initiative, subject to definitive agreements and applicable regulatory approvals. The release gives no value for G42’s projects and does not allocate a share of the wider UAE–Greece package to these MoUs. Milestones to watch include a site and capacity for any proposed data centre, the scope of public-service pilots, financing and approvals, and whether the memorandums lead to binding contracts.